ArticleInternational journal of clinical oncology2024

Gustave Roussy Immune score as a prognostic biomarker in patients with platinum-refractory metastatic urothelial carcinoma treated with pembrolizumab: YUSHIMA study.

Kenji Tanabe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.